Women's health pipelines by company
9 companies are lead sponsor of at least 2 open trials across the conditions TrialsForHer tracks (Endometriosis, PCOS, Menopause). Universities, hospitals and government sponsors are left out.
| Company | Open trials | Active trials | Conditions | Phases (active) | Next primary completion |
|---|---|---|---|---|---|
| Astellas Full pipeline page → | 2 | 4 | Menopause | Phase 3: 3, Observational: 1 | 28 Feb 2027 (est.) |
| Bayer Full pipeline page → | 2 | 5 | Menopause | Phase 3: 2, Phase 1: 2, Observational: 1 | 22 Feb 2027 (est.) |
| Endo Health | 2 | 2 | Menopause, PCOS | N/A (non-drug): 2 | May 2027 (est.) |
| Mucosa Innovations | 2 | 2 | Menopause | N/A (non-drug): 1, Observational: 1 | Dec 2026 (est.) |
| Samphire Group | 2 | 2 | Endometriosis, Menopause | N/A (non-drug): 1, Observational: 1 | 1 Jan 2027 (est.) |
| SRI International | 2 | 2 | Menopause | N/A (non-drug): 2 | 15 Sep 2027 (est.) |
| Stratpharma | 2 | 2 | Menopause | N/A (non-drug): 2 | Jun 2028 (est.) |
| Sumitomo Pharma Full pipeline page → | 2 | 3 | Endometriosis | Phase 3: 1, Observational: 2 | May 2027 (est.) |
| ZIWIG Full pipeline page → | 2 | 3 | Endometriosis | N/A (non-drug): 1, Observational: 2 | Dec 2026 (est.) |
Companies with 3 or more active trials have their own pipeline page; for smaller pipelines the registry IDs are listed under the company name. Open = recruiting or not yet recruiting. Active also counts trials whose recruitment has ended but which haven't finished. Sponsor names are grouped when they differ only by a legal suffix (for example "AG" or "Inc."). Industry status comes from each registry's sponsor type. Next primary completion uses ClinicalTrials.gov records only; dates marked "est." are the sponsor's estimates.
Track women's-health pipelines every Monday
New trials, phase changes, stopped trials and new sponsors across the conditions we track, with registry links.
Your ticks help us prioritise what to build. They don't commit you to anything, and no payment is taken.